LON:VEC

Vectura Group (VEC) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
164.80
164.80
52-Week Range
N/A
Volume
203,761 shs
Average Volume
3.37 million shs
Market Capitalization
£1.01 billion
P/E Ratio
8.20
Dividend Yield
23.06%
Price Target
N/A
VEC stock logo

About Vectura Group Stock (LON:VEC)

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.

VEC Stock News Headlines

VEC.L Regulatory News
Nestle’s Lessons From Joining the Dud Deals Club
Blow to PMI as top executives quit Vectura
Metro Group
See More Headlines
Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
9,200
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£190.60 million
Book Value
GBX 91.70 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.01 billion
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. William Downie (Age 54)
    CEO & Exec. Director
    Comp: $538.92k
  • Mr. Paul Andrew Fry (Age 54)
    CFO & Exec. Director
    Comp: $807k
  • Mr. Anthony Fitzpatrick
    Exec. VP of Operations
  • Dr. Geraldine Venthoye
    Chief Scientific Officer & Exec. VP of Product Devel.
  • Elizabeth Knowles
    VP of Investor Relations
  • Mr. John Murphy (Age 68)
    Gen. Counsel & Company Sec.
  • David Ginivan
    VP of Corp. Communications
  • Ms. Christina Olsen
    Exec. VP of Corp. Strategy & Communications
  • Ms. Joanne Hombal (Age 47)
    Exec. VP of HR
  • Mr. Roger Heerman (Age 48)
    Exec. VP of Commercial & Bus. Devel.

VEC Stock Analysis - Frequently Asked Questions

Is Vectura Group a good dividend stock?

Vectura Group (LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for VEC.

What other stocks do shareholders of Vectura Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT).

How do I buy shares of Vectura Group?

Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:VEC) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners